CCI Approves Strategic Healthcare Sector Combination Involving TPG and GIC
ECONOMY & POLICY

CCI Approves Strategic Healthcare Sector Combination Involving TPG and GIC

The Competition Commission of India (CCI) has approved a proposed combination involving multiple entities, including Waverly Pte. Ltd., TPG Growth V SF Markets Pte. Ltd., TPG Growth III SF Pte. Ltd., Asia Healthcare Holdings Pte. Ltd. (AHH Singapore), Rhea Healthcare Private Limited, Asia Healthcare Advisory Holdings LLP (AHH LLP), and Asian Institute of Nephrology and Urology Private Limited (AINU).

Key aspects of the proposed combination include:

Waverly’s planned subscription to Ordinary Shares and Class F Redeemable Preference Shares in AHH Singapore.

Specific rights for Growth V in AHH Singapore, Rhea, and AHH LLP.

Certain rights for Growth III related to AHH Singapore, specifically concerning AINU and its downstream entities.

Rhea’s acquisition of full ownership of AHH Singapore’s shareholding in AINU (the “AINU Transfer”).

Proposed equity share issuance by Rhea to AHH Singapore as consideration for the AINU Transfer.

Growth III and Growth V are investment funds managed by TPG Inc., a global investment firm. The TPG Group, including its subsidiaries and affiliates, operates primarily in sectors like technology, healthcare, consumer goods, and financial services.

Waverly is a wholly owned subsidiary of Lathe Investment Pte. Ltd., which is in turn wholly owned by GIC (Ventures) Pte. Ltd. Waverly is part of a group of investment holding companies managed by GIC Special Investments Private Limited.

AHH is a Singapore-based company focused on long-term investments in healthcare services across India, particularly in maternal, child, urology, nephrology, and related fields. It is jointly owned by the TPG and GIC groups.

Rhea operates a hospital chain specialising in women’s healthcare and fertility services and is set to merge with Nova Medical Centres Private Limited. Rhea operates in 19 states and 3 union territories in India.

AINU, located in South India, specialises in urology, nephrology, dialysis, and kidney transplants, with a network of seven hospitals across various cities.

AHH LLP provides advisory services to AHH Singapore and its downstream entities in strategy, finance, and operational matters, excluding investment management.

A detailed order from the Commission will follow.

The Competition Commission of India (CCI) has approved a proposed combination involving multiple entities, including Waverly Pte. Ltd., TPG Growth V SF Markets Pte. Ltd., TPG Growth III SF Pte. Ltd., Asia Healthcare Holdings Pte. Ltd. (AHH Singapore), Rhea Healthcare Private Limited, Asia Healthcare Advisory Holdings LLP (AHH LLP), and Asian Institute of Nephrology and Urology Private Limited (AINU). Key aspects of the proposed combination include: Waverly’s planned subscription to Ordinary Shares and Class F Redeemable Preference Shares in AHH Singapore. Specific rights for Growth V in AHH Singapore, Rhea, and AHH LLP. Certain rights for Growth III related to AHH Singapore, specifically concerning AINU and its downstream entities. Rhea’s acquisition of full ownership of AHH Singapore’s shareholding in AINU (the “AINU Transfer”). Proposed equity share issuance by Rhea to AHH Singapore as consideration for the AINU Transfer. Growth III and Growth V are investment funds managed by TPG Inc., a global investment firm. The TPG Group, including its subsidiaries and affiliates, operates primarily in sectors like technology, healthcare, consumer goods, and financial services. Waverly is a wholly owned subsidiary of Lathe Investment Pte. Ltd., which is in turn wholly owned by GIC (Ventures) Pte. Ltd. Waverly is part of a group of investment holding companies managed by GIC Special Investments Private Limited. AHH is a Singapore-based company focused on long-term investments in healthcare services across India, particularly in maternal, child, urology, nephrology, and related fields. It is jointly owned by the TPG and GIC groups. Rhea operates a hospital chain specialising in women’s healthcare and fertility services and is set to merge with Nova Medical Centres Private Limited. Rhea operates in 19 states and 3 union territories in India. AINU, located in South India, specialises in urology, nephrology, dialysis, and kidney transplants, with a network of seven hospitals across various cities. AHH LLP provides advisory services to AHH Singapore and its downstream entities in strategy, finance, and operational matters, excluding investment management. A detailed order from the Commission will follow.

Next Story
Infrastructure Transport

MMRDA advances 250 m on Orange Gate–Marine Drive tunnel

The Mumbai Metropolitan Region Development Authority (MMRDA) has completed 250 m of underground tunnelling for the Orange Gate–Marine Drive Urban Road Tunnel using India’s largest slurry shield tunnel boring machine (TBM) deployed for an urban road project.The project involves twin tunnels extending over 7 km beneath critical transport corridors, including Central Railway, Western Railway and Metro Line 3. The work requires high-precision engineering to navigate densely developed urban infrastructure.Once completed, the tunnel is expected to reduce travel time between Orange Gate and Marin..

Next Story
Infrastructure Urban

Hindustan Zinc Pays Rs 188.46 Billion in FY26

Hindustan Zinc contributed Rs 188.46 billion to the public exchequer in FY 2025-26, according to its 9th Tax Transparency Report. The contribution, equivalent to 46 per cent of the company’s revenue, included direct and indirect taxes, government royalties, dividends to the Government of India, withholding taxes and other statutory levies.The company’s five-year cumulative contribution to the exchequer stood at Rs 915.72 billion. In FY26, Hindustan Zinc reported revenue of Rs 408.44 billion, EBITDA of Rs 221.62 billion and profit after tax of Rs 138.32 billion. It also achieved its highest..

Next Story
Infrastructure Urban

World of Concrete India 2026 Opens in Mumbai

Informa Markets in India will host the 12th edition of World of Concrete India 2026 from 3–5 June 2026 at the Bombay Exhibition Centre, Mumbai. The specialised B2B exhibition will bring together manufacturers, suppliers, contractors, developers, architects, consultants, infrastructure companies, project leaders and government stakeholders.The event is expected to feature over 350 brands and more than 18,000 trade professionals. It will cover concrete and cement, dry mortar, precast technologies, formwork, construction chemicals, industrial and commercial flooring, scaffolding, safety solutio..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement